Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure

This publication has 21 references indexed in Scilit:

• A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge
  Journal of Allergy and Clinical Immunology, 2000
• Effect of Zafirlukast (Accolate) on Cellular Mediators of Inflammation
  American Journal of Respiratory and Critical Care Medicine, 1998
• Determinants of airway responses to cat allergen: Comparison of environmental challenge to quantitative nasal and bronchial allergen challenge
  Journal of Allergy and Clinical Immunology, 1997
• Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics.
  American Journal of Respiratory and Critical Care Medicine, 1997
• Comparison of two methods of collecting induced sputum in asthmatic subjects
  European Respiratory Journal, 1996
• Effects of Loratadine and Terfenadine on the Induced Nasal Allergic Reaction
  JAMA Otolaryngology–Head & Neck Surgery, 1996
• The leukotriene D4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis.
  American Journal of Respiratory and Critical Care Medicine, 1995
• The association of individual allergen reactivity with respiratory disease in a national sample: Data from the second National Health and Nutrition Examination Survey, 1976–1980 (NHANES II)
  Journal of Allergy and Clinical Immunology, 1992
• Effect of the oral leukotriene antagonist, ICI 204,219, on antigen-induced bronchoconstriction in subjects with asthma
  Journal of Allergy and Clinical Immunology, 1992
• Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects
  The Lancet, 1991